556 Razor for Razor Bumps

Age: 18 - 65

Sex: Male

Trial Phase: Academic

Sponsor: Wake Forest University Health Sciences

Disqualifiers: Electric shavers, Recent beard removal, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 4

Duration: 12 weeks

40 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on stable oral antibiotics, you can continue using them.

What is the purpose of this trial?

The purpose of this research study is to evaluate the improvement in overall shave satisfaction, the appearance of skin irritation from shaving, and the razor related inflammation of the hair follicles when using a new razor technology in a regular shaving regimen as well as a new razor technology in a shaving regimen that includes a pre-shave gel, cleansing brush and shaving gel.

Research Team

Amy McMichael, MD

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for men aged 20-60 who wet shave with a blade at least three times weekly, are willing to shave five times per week during the study, and have mild to moderate skin irritation from shaving. Participants should have experienced these symptoms for two years but can't join if they've recently changed their use of oral antibiotics or topical prescriptions, don't usually wet shave with a blade, or have removed a beard in the last two months.

Inclusion Criteria

I have had skin irritation from shaving for at least two years.

I experience mild to moderate skin irritation from shaving.

I am between 20 and 60 years old.

Exclusion Criteria

Individuals who do not wet shave with a bladed razor, or who use electric shavers

I have recently changed my prescription skin treatments.

I haven't changed my oral antibiotic use in the last 4 weeks.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the 556 razor with regular shaving products or with a regimen including pre-shave gel, cleansing brush, and shaving gel

12 weeks

Baseline, Week 4, Week 8, Week 12

Follow-up

Participants are monitored for changes in shaving satisfaction and skin irritation

4 weeks

Treatment Details

Interventions

• 556 Razor

Trial Overview The study tests a new razor technology both alone and combined with additional shaving products like pre-shave gel and cleansing brush. It aims to assess improvements in overall satisfaction with shaving, reduction of skin irritation appearance, and inflammation caused by razors.

Participant Groups

Group I: Regimen Experimental Treatment 1 Intervention

Subject will use the 556 razor with the Pre-shave Gel, Cleaning Brush, and Shaving Gel and shave at least 5 or more times per week.

Group II: Razor Group Active Control 1 Intervention

Subject will use the 556 razor with regular shaving products, and shave at least 5 or more times per week

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials

1,432

Recruited

2,506,000+

Procter and Gamble

Industry Sponsor

Trials

150

Recruited

77,000+

Marc Pritchard

Procter and Gamble

Chief Marketing Officer since 2008

B.S. in Finance from Indiana University, Bloomington

Jon R. Moeller

Procter and Gamble

Chief Executive Officer since 2021

MBA from Cornell University, B.S. in Biology from Cornell University